How can neonatal jaundice resolve quickly?

Normally, neonatal jaundice may be caused by excessive bilirubin production, weak liver metabolism of bilirubin, breast milk jaundice, hemolytic jaundice, infectious jaundice, and other reasons. It is recommended to seek timely medical consultation to identify the cause and then improve the condition under a doctor's guidance through general treatment, medication, blue light therapy, and other methods. The specific analysis is as follows:

1. Excessive bilirubin production: Newborn infants have a large number of red blood cells with short lifespans. After red blood cell destruction, a large amount of bilirubin is produced, exceeding the metabolic capacity of the body and causing jaundice. Increase infant feeding frequency, 8-12 times daily, promote bowel movements and urination through frequent breastfeeding to help eliminate bilirubin.

2. Weak bilirubin metabolism by the liver: The enzyme system in the liver of newborn infants has not fully developed, resulting in insufficient capacity to process bilirubin, which leads to bilirubin accumulation in the body. Ensure the infant has adequate sleep, avoid excessive crying that consumes energy, and closely monitor bilirubin levels while observing changes in jaundice.

3. Breast milk jaundice: Certain components in breast milk affect bilirubin metabolism, leading to prolonged jaundice duration, often without other abnormal symptoms. If bilirubin levels are not high, continue breastfeeding while increasing feeding frequency; if bilirubin levels are high, temporarily stop breastfeeding for 1-3 days under a doctor's guidance, switch to formula feeding, and use a breast pump during this period to maintain milk secretion. Resume breastfeeding after jaundice subsides.

4. Hemolytic jaundice: Maternal-infant blood type incompatibility causes massive destruction of red blood cells, leading to a rapid increase in bilirubin and resulting jaundice, accompanied by anemia and hepatosplenomegaly. Under medical guidance, administer medications such as human immunoglobulin injection, albumin injection, and phenobarbital sodium tablets. In severe cases, blue light therapy is required to reduce serum bilirubin levels through the action of blue light.

5. Infectious jaundice: After infection with bacteria or viruses, infant liver function is affected, leading to bilirubin metabolism disorders and jaundice, accompanied by symptoms such as fever and poor feeding. For bacterial infections, use medications such as cefotaxime sodium injection, amoxicillin clavulanate potassium dry suspension, and azithromycin dry suspension as directed by a physician to control the infection, and combine with blue light therapy to help resolve jaundice.

In daily care, closely observe changes in the infant's skin and whites of the eyes for jaundice, and record feeding, bowel movements, and urination. Keep the infant's skin clean to avoid skin damage that may lead to infection, and provide a quiet and comfortable environment for the infant to aid recovery.